Statistics

Total Visits

Views
Achieving the deep molecular response levels required for an imatinib discontinuation trial is strongly associated with the BCR-ABL level at the first qualifying timepoint 101

Total Visits per Month

August 2019 September 2019 October 2019 November 2019 December 2019 January 2020 February 2020
Achieving the deep molecular response levels required for an imatinib discontinuation trial is strongly associated with the BCR-ABL level at the first qualifying timepoint 0 0 2 3 2 3 2

File Downloads

Views

Top Country Views

Views
United States 13
France 5
China 3
Australia 1

Top City Views

Views
Ashburn 5
Fairfield 3
Beijing 2
Seattle 2
Kaleen 1
Phoenix 1